A critical view of harmonization of regulatory requirements for Generic Drug approval submissions in ASEAN countries

Journal Title: International Journal of Drug Regulatory Affairs - Year 2019, Vol 7, Issue 1

Abstract

To ensure quality, efficacy, and safety of drugs is the prime objective of any country and respective drug regulatory authority. Countries have their own regulatory setup to ensure the proper execution of drug regulatory guidelines in their country. There are several regional organization in world, ASEAN is one of them. It is Association of Southeast nations. ASEAN is very well representing its countries on global platform. The step of harmonization of drug regulatory guidelines by ASEAN is seen as major step taken by an Asian regional organization. ASEAN is an emerging market and every country has its own needs. As research and development sector is only developed in Singapore in ASEAN region so, generics emerge as a tool for other countries to fulfill UHC goals and Vision 2020 ASEAN. Every country has the different procedure for generic drug registration application approval. To clearly understand the procedure of generic drug registration application approval process we have gone through various guidelines and literature. There are 10 members in ASEAN i.e. Singapore, Malaysia, Thailand, Indonesia, Philippines, Brunei Darussalam, Laos PDR, Myanmar, Vietnam, and Cambodia. Each one’s generic drug approval process, requirements and effects on pharmaceutical trade after implementation of ACTD is explained in this research work. This research work also includes the statistical analysis and suggestions on how other countries and regional organization follow the model of ASEAN for drug regulatory harmonization procedure.

Authors and Affiliations

Jyoti Ghangas, Neha Jain, Anshuman Sinha

Keywords

Related Articles

Nanoparticles and target Drug delivery for cancer treatment: A Comprehensive review

In the healthcare industry, the biggest challenges are cancer. However, there are several drugs are available for the treatment of cancer. In these treatments cure cancer affecting the collateral toxicity to healthy cell...

Informed Consent form in Clinical Trial

Informed consent form is a vital requirement for research study on the human participant. It is the consent which is given by the subject before participate in clinical trial. Informed consent mainly came in existence af...

GLOBAL REGULATORY APPROACH TOWARDS M-HEALTH

The past decade has witnessed rapid advancement in telecommunication and computer technologies. The smart phone is one result of that technological development and has been adopted by hundreds of millions of people world...

A STUDY ON HEAMPHILUS INFLUANZAE TYPE B DISEASE CAUSING ANTIGENS: AN APPROACH OF EPITOPE PREDICTION, ANTIGENICITY AND IMMUNOGENICITY PREDICTION

Vaccines work by mimicking disease agents and stimulating the immune system which in turn builds a defence mechanism against the disease causing agents. Some of the vaccines contain a part of the disease causing agents w...

STEVIA AN UNTOUCHED NATURE’S GIFT CAN BE A BOON TO DIABETIC

Plants and fungi are a vital part of healthcare. Over 80% of the global population rely on traditional medicine, much of which is based on plant remedies. Traditional Chinese medicine alone uses over 5,000 plant species....

Download PDF file
  • EP ID EP495697
  • DOI 10.22270/ijdra.v7i1.297
  • Views 90
  • Downloads 0

How To Cite

Jyoti Ghangas, Neha Jain, Anshuman Sinha (2019). A critical view of harmonization of regulatory requirements for Generic Drug approval submissions in ASEAN countries. International Journal of Drug Regulatory Affairs, 7(1), 13-24. https://europub.co.uk/articles/-A-495697